Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Trading Update

30 Jan 2014 07:00

RNS Number : 8428Y
Spectra Systems Corporation
30 January 2014
 



January 30, 2014

 

Spectra Systems Corporation

("Spectra Systems" or the "Company")

G8 Central Bank New Generation Materials and Sensor Program Cancellation and Trading Update

The Board is disappointed that a G8 central bank customer which has been funding the materials and sensor development for a new generation technology has notified the Company that it has decided to cancel this program. To date the company has demonstrated a functional sensor prototype and has had numerous successful trials of the material incorporated in the embodiment of use by the central bank.

Spectra Systems continues to own all of the developed intellectual property, specific covert materials and sensor designs developed under this program. In addition, it expects that the specific materials and data will be unclassified and will be available to the Company to use commercially with another central bank customer.

Importantly the Board is pleased to announce that phosphour sales have in the last three months recovered to levels not experienced since 2011.

In addition it expects Spectra System's performance for the year ended 31 December 2013 to be in line with market expectations. The Board expects to release the Company's preliminary results for the year ended 31 December 2013 in April 2014.

 

Nabil Lawandy, Spectra System's CEO, stated:

"The manner in which this program came to an abrupt halt is gravely disappointing and a loss to the central bank which has spent over $1MM in development of materials and sensor design. Trials were performed over the last year with success and in the last technical discussions, enthusiasm was evident for the project and the success in the refinements made over the last year. In fact, a final large scale test before incorporation into banknotes had been scheduled for 24 February of this year.

We are now free to take this fully completed technology to other central banks as a ready package paid for by the central bank rather than shareholders. We will pursue this aggressively.

In the meantime, this will have minimal impact on market expectations as only negligible revenues relating thereto had been anticipated in such expectations. In addition, this decision by the G8 central bank is not expected to have any impact on current generation business with the central bank to whom we will continue to deliver upgraded sensors throughout the year.

Whilst this news is disappointing, the Board is delighted that phosphour sales have recovered to previous levels."

 

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAFNADPLEAF
Date   Source Headline
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
2nd Oct 20137:00 amRNSAcquisition of Assets from InkSure Technologies
1st Oct 20137:00 amRNSResult of AGM
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
30th Jul 20137:00 amRNSLarge Order from Central Bank
28th Jun 20137:00 amRNSPosting of Annual Report
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM
30th Apr 20097:51 amRNSNet Asset Value(s)
29th Apr 20097:41 amRNSNet Asset Value(s)
28th Apr 20097:48 amRNSNet Asset Value(s)
27th Apr 20098:04 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.